[Form 4] FMC Corporation Insider Trading Activity

Rhea-AI Filing Summary

FMC Corporation (FMC) – Form 4 Insider Transaction

Director K’Lynne Johnson reported receipt of 339 common shares on 17 Jul 2025. The shares were issued at $0 as dividend-equivalent rights linked to previously vested RSUs. Post-transaction direct ownership rises to 34,569 shares. No open-market purchases, sales, or derivative positions were disclosed, and Johnson remains classified solely as a director.

The move represents a routine administrative increase that is immaterial relative to FMC’s share count and unlikely to affect valuation or control dynamics.

Positive

• Director’s stake increases, maintaining alignment with shareholder interests, though magnitude is modest.

Negative

• None.

Insights

Portfolio Manager

TL;DR: Small, non-cash insider accrual; negligible market impact.

The 339-share addition equates to less than 1% of Johnson’s stake and a fraction of FMC’s daily volume. Because the shares stem from dividend equivalents tied to vested RSUs, they do not reflect discretionary buying conviction. I view the filing as routine and non-informative for portfolio positioning.

Corporate Governance Analyst

TL;DR: Standard compliance disclosure; governance posture unchanged.

The Form 4 confirms proper reporting of equity earned under FMC’s director compensation plan. No change in ownership status or emergence of derivative exposure was noted. From a governance perspective, transparency is maintained, and there are no red flags or positive catalysts arising from this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Johnson KLynne

(Last) (First) (Middle)

FMC CORPORATION

2929 WALNUT STREET

(Street)

PHILADELPHIA PA 19104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FMC CORP [ FMC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/17/2025		A		339(1)	A	$0	34,569	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person.

	/s/ Sara Ponessa, attorney in fact for K'Lynne Johnson	07/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did FMC (FMC) report on 17 Jul 2025?

Director K’Lynne Johnson received 339 FMC common shares as dividend-equivalent rights.

How many FMC shares does Director Johnson now own?

After the transaction, she holds 34,569 shares directly.

Was the transaction an open-market purchase?

No. The shares were issued at $0 under dividend-equivalent provisions; no cash changed hands.

Did the Form 4 include any derivative securities?

No derivative securities were acquired or disposed of in this filing.

Is the 339-share increase material to FMC’s share count?

No. The amount is immaterial relative to FMC’s outstanding shares and daily trading volume.